Detail
LncRNA Name | uc.8+ |
Synonyms | FAM138F, F379 |
Region | GRCh38_19:76163-77686 Sequence |
Ensembl | ENSG00000282591 |
RefSeq | NR_026820 |
Circulating | ✘ |
Drug-resisitant | ✘ |
Prognostic | ✘ |
MiRNA | ✔ |
Variant | ✘ |
TF | ✘ |
Methylation | ✘ |
Cancer Name | bladder cancer |
ICD-0-3 | C67 |
Methods | microarray, qPCR, RNAi, Cell proliferation assay etc. |
Sample | bladder cancer tissues, cell lines (J82 and RT112) |
Expression Pattern | up-regulated |
Function Description | The results showed an increase of 6.5 fold for uc.8+, an increase of 2.45 fold for uc.339+, a decrease of 0.105 fold for uc.195+, and a decrease of 0.25 fold for uc.217+A in BlCa tissues compared with NBE. These results are consistent with the trend shown by microarray analysis results and indicate the primary role that uc.8+ may have in BlCa onset and progression. |
Pubmed ID | 26943042 |
Year | 2016 |
Title | Long non-coding RNA containing ultraconserved genomic region 8 promotes bladder cancer tumorigenesis |
External Links |
Links for uc.8+ | GenBank HGNC lncrnadb Noncode |
Links for bladder cancer | Omim Cosmic |
CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.